Monday, January 11, 2010

Penwest Announces Initiation of Phase IIa Clinical Trial of A0001 in Patients With Friedreich's Ataxia

PATTERSON, N.Y., Jan. 11, 2010 (GLOBE NEWSWIRE)

No comments:

Post a Comment